The results of multicenter study of efficacy of Helicobacter pylori eradication therapy, conducted according to the recommendations of Maastricht V Consensus Report
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 1
Abstract
Objective — to study efficacy and safety of two weeks quadruple therapy with high doses of pantoprazole, bismuth subcitrate, clarithromycin, amoxicillin with concomitant adjuvant symbiotic therapy (Saccharomyces boulardii, Lactobacillus rhamnosus, prebiotic inulin) in the eradication therapy for Helicobacter pylori. Materials and methods. In five centers, thirty patients aged 18 — 65 years with Helicobacter pylori-associated diseases (functional dyspepsia, chronic antral gastritis and peptic duodenal ulcers) were diagnosed and treated. The Helicobacter pylori status was confirmed by rapid urease test, 13С-Urea breath test, enzyme immunoassay with detection of IgG antibodies for Helicobacter pylori. Efficacy of eradication evaluated after four weeks of treatment’s termination with 13С-Urea breath test of Stool Antigen Helicobacter pylori test. Results. Twenty-nine patients completed the treatment protocol in full. H.pylori infection eradication was confirmed in 96.5 % of patients, compliant with the protocol. The mild transitory side effects of therapy were reported in 11 patients (36.6 %), mostly often diarrhea, nausea and black coloring of the feces. Four patients (13 %) reported about appearance of two side effects. The treatment was preliminary terminated in one case because of side effect due to severe nausea on the tenth day of treatment. Conclusions. The studied regimen of quadruple eradication therapy for Helicobacter pylori infection with high doses of pantoprazole, bismuth subcitrate, clarithromycin and amoxicillin with adjuvant treatment by symbiotic Opephera provided eradication of Helicobacter pylori infection in 96.5 % of patients.
Authors and Affiliations
O. V. Shvets, О. O. Bondarenko, O. M. Аgibalov, N. I. Korolyova, N. V. Belyayeva, О. О. Ksenchin
Keywords
Related Articles
- EP ID EP508570
- DOI 10.30978/MG-2019-1-87
- Views 152
- Downloads 0
The role of inflammation and anti-inflammatory therapy in irritable bowel syndrome (review and results of own research)
The paper presents relevant data on the pathogenetic role of intestinal mucous inflammation at irritable bowel syndrome (IBS). It has been shown that with some IBS subtypes, especially post-infectious IBS, the inflammati...
Vegetative accompaniment of the combined course of gastroesophageal reflux disease in young patients with autoimmune thyroiditis
Objective — to establish the presence of autonomic dysfunction and to assess the frequency and severity of its manifestations in patients with autoimmune thyroiditis (AIT) and gastroesophageal reflux disease (GERD) with...
The role of intestinal microbiota in the development of metabolic disorders
It is known that ahuman intestine contains more than 100 trillion microbial cells, which play an important role in the regulation of human metabolism through their symbiotic interactions with the host. The modified intes...
Gastroesophageal reflux disease in patients with metabolic syndrome: the peculiarities of clinical course and the modern approaches to treatment
The article presents a data on prevalence of gastroesophageal reflux disease and Barrett’s esophagus in patients with metabolic syndrome. The main etiopathogenetic mechanisms of formation and modern approaches to therapy...
The gastroenterological manifestations of methotrexate effects in pediatric patients with the juvenile idiopathic arthritis
The paper elucidates the most prevalent gastroenterological manifestations of methotrexate effects in the treatment of juvenile idiopathic arthritis (JIA) in pediatric patients. Some considerable changes took place in th...